Skip to main content
The British Journal of Venereal Diseases logoLink to The British Journal of Venereal Diseases
. 1980 Oct;56(5):314–318. doi: 10.1136/sti.56.5.314

Vaginal chemoprophylaxis in the reduction of reinfection in women with gonorrhoea. Clinical evaluation of the effectiveness of a vaginal contraceptive.

C H Cole, T G Lacher, J C Bailey, D L Fairclough
PMCID: PMC1045814  PMID: 7427702

Abstract

A clinical investigation was undertaken to determine if chemoprophylaxis in the form of a contraceptive pessary would reduce the rate of reinfection with gonorrhoea in 1245 female patients attending a venereal disease clinic. After the introduction of the pessary the reinfection rate over a 16-week period was 19% compared with 40% in the control clinic patients. It was also found that women could be motivated to use a pessary; 65% of women used pessaries before sexual intercourse at least some of the time. High reinfection rates in venereal disease clinic patients emphasise the need for improved methods of preventing reinfection. Vaginal chemoprophylaxis appears to be an alternative means of reducing gonorrhoea morbidity.

Full text

PDF
314

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bolch O. H., Jr, Warren J. C. In vitro effects of Emko on Neisseria gonorrhoeae and Trichomonas vaginalis. Am J Obstet Gynecol. 1973 Apr 15;115(8):1145–1148. doi: 10.1016/0002-9378(73)90566-8. [DOI] [PubMed] [Google Scholar]
  2. Cowan M. E., Cree G. E. A note on the susceptibility of N. gonorrhoeae to contraceptive agent Nonyl-P. Br J Vener Dis. 1973 Feb;49(1):65–66. doi: 10.1136/sti.49.1.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cutler J. C., Utidjian H. M., Singh B., Arnold R. C. Studies on development of a vaginal preparation providing both prophylaxis against venereal disease, other genital infections, and contraception. I. Venereal disease prophylaxis, past experience, present status and plans for future studies. Mil Med. 1973 Feb;138(2):88–91. [PubMed] [Google Scholar]
  4. Darrow W. W., Wiesner P. J. Personal prophylaxis for venereal diseases. JAMA. 1975 Aug 4;233(5):444–446. [PubMed] [Google Scholar]
  5. Donsky H. J. Nonoxynol 9 cream for genital herpes simplex. N Engl J Med. 1979 Feb 15;300(7):371–371. doi: 10.1056/nejm197902153000724. [DOI] [PubMed] [Google Scholar]
  6. Lee T. Y., Utidjian H. M., Singh B., Carpenter U., Cutler J. C. Potential impact of chemical prophylaxis on the incidence of gonorrhoea. Br J Vener Dis. 1972 Oct;48(5):376–380. doi: 10.1136/sti.48.5.376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Singh B., Cutler J. C., Utidjian H. M. Studies on the development of a vaginal preparation providing both prophylaxis against venereal disease and other genital infections and contraception. II. Effect in vitro of vaginal contraceptive and non-contraceptive preparations on Treponema pallidum and Neisseria gonorrhoeae. Br J Vener Dis. 1972 Feb;48(1):57–64. doi: 10.1136/sti.48.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Venereal Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES